|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
US5587308A
(en)
|
1992-06-02 |
1996-12-24 |
The United States Of America As Represented By The Department Of Health & Human Services |
Modified adeno-associated virus vector capable of expression from a novel promoter
|
|
US6242568B1
(en)
|
1994-01-18 |
2001-06-05 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
|
US6140466A
(en)
|
1994-01-18 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
|
USRE39229E1
(en)
|
1994-08-20 |
2006-08-08 |
Gendaq Limited |
Binding proteins for recognition of DNA
|
|
GB9824544D0
(en)
|
1998-11-09 |
1999-01-06 |
Medical Res Council |
Screening system
|
|
US5789538A
(en)
|
1995-02-03 |
1998-08-04 |
Massachusetts Institute Of Technology |
Zinc finger proteins with high affinity new DNA binding specificities
|
|
US6699663B1
(en)
|
1995-12-14 |
2004-03-02 |
The General Hospital Corporation |
Molecular sequence of swine retrovirus
|
|
US5846946A
(en)
|
1996-06-14 |
1998-12-08 |
Pasteur Merieux Serums Et Vaccins |
Compositions and methods for administering Borrelia DNA
|
|
US5925523A
(en)
|
1996-08-23 |
1999-07-20 |
President & Fellows Of Harvard College |
Intraction trap assay, reagents and uses thereof
|
|
GB9703369D0
(en)
|
1997-02-18 |
1997-04-09 |
Lindqvist Bjorn H |
Process
|
|
GB2338237B
(en)
|
1997-02-18 |
2001-02-28 |
Actinova Ltd |
In vitro peptide or protein expression library
|
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
US6410248B1
(en)
|
1998-01-30 |
2002-06-25 |
Massachusetts Institute Of Technology |
General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
|
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
US6599692B1
(en)
|
1999-09-14 |
2003-07-29 |
Sangamo Bioscience, Inc. |
Functional genomics using zinc finger proteins
|
|
US7070934B2
(en)
|
1999-01-12 |
2006-07-04 |
Sangamo Biosciences, Inc. |
Ligand-controlled regulation of endogenous gene expression
|
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US7030215B2
(en)
|
1999-03-24 |
2006-04-18 |
Sangamo Biosciences, Inc. |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
|
EP1083231A1
(en)
|
1999-09-09 |
2001-03-14 |
Introgene B.V. |
Smooth muscle cell promoter and uses thereof
|
|
AU776576B2
(en)
|
1999-12-06 |
2004-09-16 |
Sangamo Biosciences, Inc. |
Methods of using randomized libraries of zinc finger proteins for the identification of gene function
|
|
US6689558B2
(en)
|
2000-02-08 |
2004-02-10 |
Sangamo Biosciences, Inc. |
Cells for drug discovery
|
|
AU2001263155A1
(en)
|
2000-05-16 |
2001-11-26 |
Massachusetts Institute Of Technology |
Methods and compositions for interaction trap assays
|
|
US6627424B1
(en)
|
2000-05-26 |
2003-09-30 |
Mj Bioworks, Inc. |
Nucleic acid modifying enzymes
|
|
US7067317B2
(en)
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
|
US7169874B2
(en)
|
2001-11-02 |
2007-01-30 |
Bausch & Lomb Incorporated |
High refractive index polymeric siloxysilane compositions
|
|
US7262054B2
(en)
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
|
JP4638225B2
(ja)
|
2002-05-30 |
2011-02-23 |
ザ スクリプス リサーチ インスティテュート |
銅を触媒とするアジドとアセチレンのライゲーション
|
|
US7361635B2
(en)
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
|
US9267932B2
(en)
|
2003-05-28 |
2016-02-23 |
The Johns Hopkins University |
Synthetic mammalian retrotransposon gene
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US7070941B2
(en)
|
2003-11-17 |
2006-07-04 |
Board Of Regents, The University Of Texas System |
Methods and compositions for tagging via azido substrates
|
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
AU2005232665B2
(en)
|
2004-04-08 |
2010-05-13 |
Sangamo Therapeutics, Inc. |
Methods and compositions for treating neuropathic and neurodegenerative conditions
|
|
US7253273B2
(en)
|
2004-04-08 |
2007-08-07 |
Sangamo Biosciences, Inc. |
Treatment of neuropathic pain with zinc finger proteins
|
|
AU2005244258B2
(en)
|
2004-04-09 |
2010-07-01 |
Monsanto Technology Llc |
Compositions and methods for control of insect infestations in plants
|
|
DE102004034461B4
(de)
|
2004-07-16 |
2008-02-07 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren
|
|
AU2005274948B2
(en)
|
2004-07-16 |
2011-09-22 |
Genvec, Inc. |
Vaccines against aids comprising CMV/R-nucleic acid constructs
|
|
US20110214199A1
(en)
|
2007-06-06 |
2011-09-01 |
Monsanto Technology Llc |
Genes and uses for plant enhancement
|
|
US8404658B2
(en)
|
2007-12-31 |
2013-03-26 |
Nanocor Therapeutics, Inc. |
RNA interference for the treatment of heart failure
|
|
US8394604B2
(en)
|
2008-04-30 |
2013-03-12 |
Paul Xiang-Qin Liu |
Protein splicing using short terminal split inteins
|
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
MX360460B
(es)
|
2008-10-20 |
2018-11-05 |
Alnylam Pharmaceuticals Inc |
Composiciones y metodos para inhibir la expresion de transtiretina.
|
|
GB0901593D0
(en)
|
2009-01-30 |
2009-03-11 |
Touchlight Genetics Ltd |
Production of closed linear DNA
|
|
US10113156B2
(en)
|
2009-03-04 |
2018-10-30 |
Board Of Regents, The University Of Texas System |
Stabilized reverse transcriptase fusion proteins
|
|
KR101766408B1
(ko)
|
2009-06-10 |
2017-08-10 |
알닐람 파마슈티칼스 인코포레이티드 |
향상된 지질 조성물
|
|
AU2010325563B2
(en)
|
2009-11-27 |
2017-02-02 |
Basf Plant Science Company Gmbh |
Chimeric endonucleases and uses thereof
|
|
EP2500434A1
(en)
|
2011-03-12 |
2012-09-19 |
Association Institut de Myologie |
Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
|
|
US8846883B2
(en)
|
2011-08-16 |
2014-09-30 |
University Of Southhampton |
Oligonucleotide ligation
|
|
EP3431497B1
(en)
|
2012-06-27 |
2022-07-27 |
The Trustees of Princeton University |
Split inteins, conjugates and uses thereof
|
|
CN102723640B
(zh)
|
2012-07-09 |
2015-08-26 |
东莞中探探针有限公司 |
磁性连接器结构
|
|
CN113355357B
(zh)
*
|
2012-12-12 |
2024-12-03 |
布罗德研究所有限公司 |
对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
|
|
CN107879960B
(zh)
|
2013-03-08 |
2021-06-22 |
诺华股份有限公司 |
用于传递活性成分的脂质和脂质组合物
|
|
RU2662932C2
(ru)
|
2013-03-14 |
2018-07-31 |
Карибо Биосайенсиз, Инк. |
Композиции и способы с участием нуклеиновых кислот, нацеленных на нуклеиновые кислоты
|
|
EP3041940B1
(en)
*
|
2013-09-02 |
2020-10-28 |
Cellectis |
Rna based method to obtain stably integrated retroviral vectors
|
|
CN106459995B
(zh)
|
2013-11-07 |
2020-02-21 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
EP3083556B1
(en)
|
2013-12-19 |
2019-12-25 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
JP2017503521A
(ja)
|
2014-01-22 |
2017-02-02 |
ライフ テクノロジーズ コーポレーション |
高温核酸合成で使用するための新規な逆転写酵素
|
|
US9879283B2
(en)
|
2014-10-09 |
2018-01-30 |
Life Technologies Corporation |
CRISPR oligonucleotides and gene editing
|
|
PL3386484T3
(pl)
|
2015-12-10 |
2022-07-25 |
Modernatx, Inc. |
Kompozycje i sposoby dostarczania środków terapeutycznych
|
|
PT3408292T
(pt)
|
2016-01-29 |
2023-07-19 |
Univ Princeton |
Inteínas divididas com excecional atividade de splicing
|
|
AU2017219605B2
(en)
|
2016-02-15 |
2023-04-13 |
Temple University - Of The Commonwealth System Of Higher Education |
Excision of retroviral nucleic acid sequences
|
|
LT3436077T
(lt)
|
2016-03-30 |
2025-06-25 |
Intellia Therapeutics, Inc. |
Lipidų nanodalelių vaisto formos, skirtos crispr/cas komponentams
|
|
US11427838B2
(en)
|
2016-06-29 |
2022-08-30 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders
|
|
WO2018045321A1
(en)
|
2016-09-02 |
2018-03-08 |
North Carolina State University |
Methods and compositions for modification of plastid genomes
|
|
US20190255106A1
(en)
|
2016-09-07 |
2019-08-22 |
Flagship Pioneering Inc. |
Methods and compositions for modulating gene expression
|
|
US11280790B2
(en)
|
2016-10-04 |
2022-03-22 |
Svar Life Science Ab |
System and products for improved quantification of ADCC activity
|
|
KR102622411B1
(ko)
|
2016-10-14 |
2024-01-10 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 에디터의 aav 전달
|
|
US20190330620A1
(en)
|
2016-10-14 |
2019-10-31 |
Emendobio Inc. |
Rna compositions for genome editing
|
|
US20180127759A1
(en)
|
2016-10-28 |
2018-05-10 |
Massachusetts Institute Of Technology |
Dynamic genome engineering
|
|
EP4545649A3
(en)
|
2016-11-11 |
2025-06-04 |
Bio-Rad Laboratories, Inc. |
Methods for processing nucleic acid samples
|
|
US9816093B1
(en)
|
2016-12-06 |
2017-11-14 |
Caribou Biosciences, Inc. |
Engineered nucleic acid-targeting nucleic acids
|
|
SG10202106058WA
(en)
|
2016-12-08 |
2021-07-29 |
Intellia Therapeutics Inc |
Modified guide rnas
|
|
WO2018170184A1
(en)
|
2017-03-14 |
2018-09-20 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
US11667899B2
(en)
|
2017-06-27 |
2023-06-06 |
Yale University |
Reverse transcriptase and methods of use
|
|
CA3073448A1
(en)
|
2017-08-23 |
2019-02-28 |
The General Hospital Corporation |
Engineered crispr-cas9 nucleases with altered pam specificity
|
|
EP3679143A1
(en)
|
2017-09-08 |
2020-07-15 |
Life Technologies Corporation |
Methods for improved homologous recombination and compositions thereof
|
|
WO2019067910A1
(en)
|
2017-09-29 |
2019-04-04 |
Intellia Therapeutics, Inc. |
POLYNUCLEOTIDES, COMPOSITIONS AND METHODS FOR GENOMIC EDITION
|
|
US20230140670A1
(en)
|
2017-09-29 |
2023-05-04 |
Intellia Therapeutics, Inc. |
Formulations
|
|
WO2019070843A1
(en)
|
2017-10-03 |
2019-04-11 |
Board Of Regents, The University Of Texas System |
INVERSE TRANSCRIPTASE WITH LTR-FREE BACKLIGHTS AND USES THEREOF
|
|
CA3084185A1
(en)
|
2017-12-06 |
2019-06-13 |
Generation Bio Co. |
Gene editing using a modified closed-ended dna (cedna)
|
|
JP2021506251A
(ja)
|
2017-12-14 |
2021-02-22 |
クリスパー セラピューティクス アーゲー |
新規ｒｎａプログラム可能エンドヌクレアーゼ系、ならびにゲノム編集および他の適用におけるその使用
|
|
EP3728589A4
(en)
|
2017-12-22 |
2021-11-03 |
G+Flas Life Sciences |
CHEMICAL GENOMIC ENGINEERING MOLECULES AND PROCESSES
|
|
MA52116A
(fr)
|
2018-03-02 |
2021-01-06 |
Generation Bio Co |
Vecteurs d'adn à extrémité fermée (cedna) pour l'insertion de transgènes au niveau de havres génomiques sécuritaires (gsh) dans des génomes humains et murins
|
|
WO2019178428A1
(en)
|
2018-03-14 |
2019-09-19 |
Arbor Biotechnologies, Inc. |
Novel crispr dna and rna targeting enzymes and systems
|
|
EP3775239A4
(en)
|
2018-03-25 |
2022-01-05 |
Genetether, Inc |
MODIFIED NUCLEIC ACID EDITING SYSTEM FOR BINDING DONOR DNA
|
|
CN112533627A
(zh)
|
2018-03-27 |
2021-03-19 |
G+Flas 生命科学公司 |
序列特异性体内细胞靶向
|
|
CN112955174A
(zh)
|
2018-07-09 |
2021-06-11 |
旗舰先锋创新V股份有限公司 |
融合剂脂质体组合物和其用途
|
|
US20210355475A1
(en)
|
2018-08-10 |
2021-11-18 |
Cornell University |
Optimized base editors enable efficient editing in cells, organoids and mice
|
|
EP3844272A1
(en)
|
2018-08-28 |
2021-07-07 |
Flagship Pioneering Innovations VI, LLC |
Methods and compositions for modulating a genome
|
|
EP3847254A4
(en)
|
2018-09-07 |
2022-08-10 |
Beam Therapeutics Inc. |
COMPOSITIONS AND METHODS FOR DELIVERING A NUCLEOBASE EDITING SYSTEM
|
|
US20210079404A9
(en)
|
2018-09-25 |
2021-03-18 |
Massachusetts Institute Of Technology |
Engineered dcas9 with reduced toxicity and its use in genetic circuits
|
|
CN113710799B
(zh)
|
2018-11-28 |
2024-11-12 |
克里斯珀医疗股份公司 |
用于在LNP中使用的编码CAS9的优化mRNA
|
|
AU2020215730A1
(en)
|
2019-01-31 |
2021-07-29 |
Beam Therapeutics Inc. |
Nucleobase editors having reduced non-target deamination and assays for characterizing nucleobase editors
|
|
US10947517B2
(en)
*
|
2019-02-15 |
2021-03-16 |
Sigma-Aldrich Co. Llc |
CRISPR/Cas fusion proteins and systems
|
|
WO2020191233A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
WO2020241869A1
(ja)
*
|
2019-05-30 |
2020-12-03 |
国立大学法人東京大学 |
２種の核酸塩基変換酵素が融合されたＣａｓタンパク質を利用したゲノム編集システム
|
|
US20220298495A1
(en)
|
2019-06-12 |
2022-09-22 |
Emendobio Inc. |
Novel genome editing tool
|
|
JP7759311B2
(ja)
|
2019-07-19 |
2025-10-23 |
フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー |
リコンビナーゼ組成物及び使用方法
|
|
US20220411777A1
(en)
|
2019-08-30 |
2022-12-29 |
The General Hospital Corporation |
C-to-G Transversion DNA Base Editors
|
|
EP4034659A4
(en)
|
2019-09-27 |
2024-10-16 |
The Broad Institute, Inc. |
PROGRAMMABLE POLYNUCLEOTIDE EDITORS FOR AMPLIFIED HOMOLOGOUS RECOMBINATION
|
|
US20220411768A1
(en)
*
|
2019-10-21 |
2022-12-29 |
The Trustees Of Columbia University In The City Of New York |
Methods of performing rna templated genome editing
|
|
CA3160186A1
(en)
*
|
2019-11-05 |
2021-05-14 |
Pairwise Plants Services, Inc. |
Compositions and methods for rna-encoded dna-replacement of alleles
|
|
CA3162499A1
(en)
|
2019-11-22 |
2021-05-27 |
Flagship Pioneering Innovations Vi, Llc |
Recombinase compositions and methods of use
|
|
CN114829594B
(zh)
|
2019-12-26 |
2025-03-21 |
新加坡科技研究局 |
核碱基编辑器
|
|
EP4085141A4
(en)
*
|
2019-12-30 |
2024-03-06 |
The Broad Institute, Inc. |
GENOME EDITING USING REVERSE TRANSCRIPTASE FOR FULLY ACTIVE CRISPR COMPLEXES
|
|
KR20230053735A
(ko)
|
2020-03-04 |
2023-04-21 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
게놈의 조정을 위한 개선된 방법 및 조성물
|
|
US20230348939A1
(en)
|
2020-03-04 |
2023-11-02 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
BR112022017713A2
(pt)
|
2020-03-04 |
2022-11-16 |
Flagship Pioneering Innovations Vi Llc |
Métodos e composições para modular um genoma
|
|
CN116209756A
(zh)
|
2020-03-04 |
2023-06-02 |
旗舰先锋创新Vi有限责任公司 |
调控基因组的方法和组合物
|
|
CA3174553A1
(en)
|
2020-03-05 |
2021-09-10 |
Flagship Pioneering Innovations Vi, Llc |
Host defense suppressing methods and compositions for modulating a genome
|
|
JP2023518395A
(ja)
|
2020-03-19 |
2023-05-01 |
インテリア セラピューティクス，インコーポレイテッド |
指向性ゲノム編集のための方法及び組成物
|
|
EP4133069A2
(en)
|
2020-04-08 |
2023-02-15 |
Astrazeneca AB |
Compositions and methods for improved site-specific modification
|
|
IL297761A
(en)
|
2020-05-08 |
2022-12-01 |
Broad Inst Inc |
Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
|
|
WO2021248102A1
(en)
|
2020-06-05 |
2021-12-09 |
Flagship Pioneering Innovations Vi, Llc |
Template guide rna molecules
|
|
AU2021403660A1
(en)
|
2020-12-16 |
2023-07-06 |
Universitat Pompeu Fabra |
Programmable transposases and uses thereof
|
|
EP4274894A2
(en)
|
2021-01-11 |
2023-11-15 |
The Broad Institute, Inc. |
Prime editor variants, constructs, and methods for enhancing prime editing efficiency and precision
|
|
CN116745428A
(zh)
|
2021-01-14 |
2023-09-12 |
加利福尼亚大学董事会 |
位点特异性基因修饰
|
|
WO2022155532A1
(en)
|
2021-01-15 |
2022-07-21 |
4M Genomics Inc. |
Polypeptide fusions or conjugates for gene editing
|
|
WO2022158898A1
(ko)
|
2021-01-21 |
2022-07-28 |
한국생명공학연구원 |
Francisella novicida cas9 모듈 기반의 역전사 효소를 사용한 유전체 치환 및 삽입 기술
|
|
US20230374476A1
(en)
|
2021-02-05 |
2023-11-23 |
University Of Massachusetts |
Prime editor system for in vivo genome editing
|
|
US20240132916A1
(en)
|
2021-02-09 |
2024-04-25 |
The Broad Institute, Inc. |
Nuclease-guided non-ltr retrotransposons and uses thereof
|
|
WO2022183210A1
(en)
|
2021-02-26 |
2022-09-01 |
Flagship Pioneering Innovations Vi, Llc |
Tissue-specific methods and compositions for modulating a genome
|
|
EP4314257A4
(en)
|
2021-04-01 |
2025-07-09 |
Prime Medicine Inc |
METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES
|
|
EP4352230A4
(en)
|
2021-06-03 |
2025-06-11 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treating Wilson's disease
|
|
WO2023283092A1
(en)
|
2021-07-06 |
2023-01-12 |
Prime Medicine, Inc. |
Compositions and methods for efficient genome editing
|
|
EP4373939A4
(en)
|
2021-07-23 |
2025-11-19 |
Prime Medicine Inc |
Genome editing compositions and treatment methods for chronic granulomatous disease
|
|
WO2023015014A1
(en)
|
2021-08-05 |
2023-02-09 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of myotonic dystrophy
|
|
WO2023015318A2
(en)
|
2021-08-05 |
2023-02-09 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of cystic fibrosis
|
|
JP2024530487A
(ja)
|
2021-08-06 |
2024-08-21 |
ザ ブロード インスティテュート，インコーポレーテッド |
改善されたプライムエディターおよび使用方法
|
|
CA3231712A1
(en)
|
2021-09-08 |
2023-03-16 |
Flagship Pioneering Innovations Vi, Llc |
Pah-modulating compositions and methods
|
|
MX2024002988A
(es)
|
2021-09-08 |
2024-06-11 |
Flagship Pioneering Innovations Vi Llc |
Composiciones y metodos moduladores de la serpina.
|
|
AU2022343268A1
(en)
|
2021-09-08 |
2024-03-28 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
JP2024534945A
(ja)
|
2021-09-10 |
2024-09-26 |
アジレント・テクノロジーズ・インク |
化学修飾を有するプライム編集のためのガイドｒｎａ
|
|
EP4413128A1
(en)
|
2021-10-08 |
2024-08-14 |
The General Hospital Corporation |
Improved crispr prime editors
|
|
EP4419688A2
(en)
|
2021-10-21 |
2024-08-28 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of usher syndrome type 3
|
|
EP4430188A1
(en)
|
2021-11-09 |
2024-09-18 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of amyotrophic lateral sclerosis
|
|
EP4430185A1
(en)
|
2021-11-09 |
2024-09-18 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of fuchs endothelial corneal dystrophy
|
|
EP4430189A1
(en)
|
2021-11-11 |
2024-09-18 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of fragile x syndrome
|
|
IL313027A
(en)
|
2021-11-24 |
2024-07-01 |
Prime Medicine Inc |
Modified prime editing guide rnas
|
|
EP4437106A2
(en)
|
2021-11-24 |
2024-10-02 |
Prime Medicine, Inc. |
Methods and compositions for inhibiting mismatch repair
|
|
WO2023108153A2
(en)
*
|
2021-12-10 |
2023-06-15 |
Flagship Pioneering Innovations Vi, Llc |
Cftr-modulating compositions and methods
|
|
EP4504921A4
(en)
|
2022-04-01 |
2026-04-15 |
Prime Medicine Inc |
METHODS AND COMPOSITIONS FOR EDITING NUCLEOTID SEQUENCES
|
|
CA3260587A1
(en)
*
|
2022-06-24 |
2023-12-28 |
Flagship Pioneering Innovations Vi, Llc |
FAH COMPOSITIONS AND MODULATION METHODS
|